精密医療の世界市場

世界の精密医療の市場規模は、2023年の542億米ドルから、予測期間中は13.2%のCAGRで推移し、2028年には1,005億米ドルの規模に成長すると予測されています。

地域別で見ると、北米市場は、2023年の226億米ドルから、13.2%のCAGRで推移し、2028年には421億米ドルの規模に成長すると予測されています。欧州市場は、2023年の141億米ドルから、13.4%のCAGRで推移し、2028年には264億米ドルの規模に成長すると予測されています。

当レポートでは、世界の精密医療の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、技術動向、ESGの展開、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要・定義

第4章 市場力学

• 市場促進要因
• 個別化医療への需要の高まり
• 技術の進歩
• 政府の取り組み
• 慢性疾患有病率の増加
• 市場の課題
• データの解釈
• データのプライバシー
• 精密医療のコスト

第5章 精密医療市場：技術別

• ビッグデータアナリティクス
• バイオインフォマティクス
• 遺伝子シーケンシング
• 創薬
• コンパニオン診断

第6章 精密医療市場：用途別

• 腫瘍
• 中枢神経系
• 免疫
• 呼吸器疾患

第7章 精密医療市場：地域別

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第8章 新興技術

第9章 M&A

第10章 競合情報

• 世界企業ランキング

第11章 企業プロファイル

• 2BPRECISE
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• CATALENT INC.
• CLINISYS
• F. HOFFMANN-LA ROCHE LTD.
• FABRIC GENOMICS
• HUMAN LONGEVITY INC.
• IQVIA HOLDINGS INC.
• JOHNSON & JOHNSON
• LIFEOMIC HOLDINGS LLC
• LONZA
• MERCK & CO. INC.
• NOVARTIS AG
• PAREXEL INTERNATIONAL CORP.
• PFIZER INC.
• SOPHIA GENETICS
• SYAPSE INC.
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Market for Precision Medicine, by Region, Through 2028
• Table 1 : Global Market for Precision Medicine, by Technology, Through 2028
• Table 2 : Global Market for Precision Medicine, by Application, Through 2028
• Table 3 : Global Market for Precision Medicine, by Region, Through 2028
• Table 4 : North American Market for Precision Medicine, by Country, Through 2028
• Table 5 : North American Market for Precision Medicine, by Technology, Through 2028
• Table 6 : North American Market for Precision Medicine, by Application, Through 2028
• Table 7 : European Market for Precision Medicine, by Country, Through 2028
• Table 8 : European Market for Precision Medicine, by Technology, Through 2028
• Table 9 : European Market for Precision Medicine, by Application, Through 2028
• Table 10 : Asia-Pacific Market for Precision Medicine, by Country, Through 2028
• Table 11 : Asia-Pacific Market for Precision Medicine, by Technology, Through 2028
• Table 12 : Asia-Pacific Market for Precision Medicine, by Application, Through 2028
• Table 13 : South American Market for Precision Medicine, by Technology, Through 2028
• Table 14 : South American Market for Precision Medicine, by Application, Through 2028
• Table 15 : Middle East and African Market for Precision Medicine, by Technology, Through 2028
• Table 16 : Middle East and African Market for Precision Medicine, by Application, Through 2028
• Table 17 : Global Market Rankings for Precision Medicine, by Company, 2022
• Table 18 : Amgen Inc.: Revenue, 2020-2022
• Table 19 : AstraZeneca: Revenue, 2020-2022
• Table 20 : AstraZeneca: Revenue, by Segment (Product Sales), 2020-2022
• Table 21 : Bristol-Myers Squibb Co.: Revenue, 2020-2022
• Table 22 : Catalent Inc.: Revenue, 2020-2022
• Table 23 : Johnson & Johnson: Revenue, 2020-2022
• Table 24 : Novartis AG: Revenue, 2020-2022
• Table 25 : Pfizer Inc.: Revenue, 2020-2022

List of Figures

• Summary Figure : Global Market for Precision Medicine, by Region, 2020-2028
• Figure 1 : Global Heart and Circulatory Disease Prevalence, 2021
• Figure 2 : Big Data Analytics in Personalized Medicine
• Figure 3 : Outline of Precision Medicine in Oncology
• Figure 4 : Common Clinical Phenotypes in Neurodegenerative and Neuropsychiatric Disorders
• Figure 5 : AstraZeneca: Revenue Share, by Therapy Area, 2022
• Figure 6 : AstraZeneca: Revenue Share, by Reporting Region, 2022
• Figure 7 : Bristol-Myers Squibb Co.: Revenue Share, by Region, 2022
• Figure 8 : Novartis AG: Revenue Share, by Region, 2022
• Figure 9 : Pfizer Inc.: Revenue Share, by Country, 2022

Highlights:

The global market for precision medicine is estimated to increase from $54.2 billion in 2023 to reach $100.5 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.

North American market for precision medicine is estimated to increase from $22.6 billion in 2023 to reach $42.1 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.

European market for precision medicine is estimated to increase from $14.1 billion in 2023 to reach $26.4 billion by 2028, at a compound annual growth rate (CAGR) of 13.4% from 2023 through 2028.

Report Scope:

This study offers a global view of the solutions provided by precision medicine in the market. This report analyzes and assesses technologies such as big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. It also provides information about the areas in which precision medicine is used, such as oncology, central nervous system disorders, immunology, respiratory conditions, and others.

BCC Research analyzes and makes projections for each market and its segmentation and assesses the regulatory environment, pipeline products, and future aspects. The report also examines the impact of COVID, discusses emerging trends in the market, and profiles leading companies in the precision medicine market such as Pfizer, Roche, AstraZeneca, Novartis, and Thermo Fisher Scientific. The report covers the major markets of North America and Europe and emerging markets such as India, China, Japan, South America, and others.

Report Includes:

• 26 tables
• A comprehensive overview and an up-to-date analysis of the global market for precision medicine
• Analyses of the global market trends, with market revenue data (sales figures) for 2020-2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussion of industry growth driving factors and major technology issues and challenges affecting the market for precision medicine as a basis for projecting demand in the next few years (2023-2028)
• Estimation of the actual market size and revenue forecast for global precision medicine market in USD million values, and corresponding market share analysis by technology type, application, end user, and region
• Insights into the recent industry structure for precision medicine technologies, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
• Review of the recent patent grants and patent applications on precision medicine technologies
• Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global precision medicine industry
• Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
• Detailed company profiles of the leading market players, including AstraZeneca, Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., and Johnson & Johnson

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview and Definition

• Definition
• Overview

Chapter 4 Market Dynamics

• Market Drivers
• Growing Demand for Personalized Medicine
• Technological Advancement
• Government Initiatives
• Rise in Chronic Disease Prevalence
• Market Challenges
• Data Interpretation
• Data Privacy
• Cost of Precision Medicine

Chapter 5 Precision Medicine Market by Technology

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics

Chapter 6 Precision Medicine Market by Application

• Oncology
• Central Nervous System
• Immunology
• Respiratory Disease

Chapter 7 Precision Medicine Market by Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 8 Emerging Technologies

• Emerging Technology in Precision Medicine

Chapter 9 Merger and Acquisitions

• Mergers and Acquisitions

Chapter 10 Competitive Intelligence

• Global Company Ranking

Chapter 11 Company Profiles

• 2BPRECISE
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• CATALENT INC.
• CLINISYS
• F. HOFFMANN-LA ROCHE LTD.
• FABRIC GENOMICS
• HUMAN LONGEVITY INC.
• IQVIA HOLDINGS INC.
• JOHNSON & JOHNSON
• LIFEOMIC HOLDINGS LLC
• LONZA
• MERCK & CO. INC.
• NOVARTIS AG
• PAREXEL INTERNATIONAL CORP.
• PFIZER INC.
• SOPHIA GENETICS
• SYAPSE INC.
• THERMO FISHER SCIENTIFIC INC.